These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33184233)

  • 1. Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals.
    van der Kall LM; Truong T; Burnham SC; Doré V; Mulligan RS; Bozinovski S; Lamb F; Bourgeat P; Fripp J; Schultz S; Lim YY; Laws SM; Ames D; Fowler C; Rainey-Smith SR; Martins RN; Salvado O; Robertson J; Maruff P; Masters CL; Villemagne VL; Rowe CC
    Neurology; 2021 Feb; 96(5):e662-e670. PubMed ID: 33184233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals.
    Nadkarni NK; Tudorascu D; Campbell E; Snitz BE; Cohen AD; Halligan E; Mathis CA; Aizenstein HJ; Klunk WE
    J Gerontol A Biol Sci Med Sci; 2019 Oct; 74(11):1753-1760. PubMed ID: 30957843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-PET imaging predicts functional decline in clinically normal individuals.
    Quenon L; Collij LE; Garcia DV; Lopes Alves I; Gérard T; Malotaux V; Huyghe L; Gispert JD; Jessen F; Visser PJ; den Braber A; Ritchie CW; Boada M; Marquié M; Vandenberghe R; Luckett ES; Schöll M; Frisoni GB; Buckley C; Stephens A; Altomare D; Ford L; Birck C; Mett A; Gismondi R; Wolz R; Grootoonk S; Manber R; Shekari M; Lhommel R; Dricot L; Ivanoiu A; Farrar G; Barkhof F; Hanseeuw BJ;
    Alzheimers Res Ther; 2024 Jun; 16(1):130. PubMed ID: 38886831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults.
    Dang C; Harrington KD; Lim YY; Ames D; Hassenstab J; Laws SM; Yassi N; Hickey M; Rainey-Smith S; Robertson J; Sohrabi HR; Salvado O; Weinborn M; Villemagne VL; Rowe CC; Masters CL; Maruff P;
    J Alzheimers Dis; 2018; 65(4):1313-1325. PubMed ID: 30149452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment.
    Groot C; Smith R; Collij LE; Mastenbroek SE; Stomrud E; Binette AP; Leuzy A; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Cho H; Lyoo CH; Frisoni GB; Peretti DE; Garibotto V; La Joie R; Soleimani-Meigooni DN; Rabinovici G; Ossenkoppele R; Hansson O
    JAMA Neurol; 2024 Aug; 81(8):845-856. PubMed ID: 38857029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.
    Doraiswamy PM; Sperling RA; Johnson K; Reiman EM; Wong TZ; Sabbagh MN; Sadowsky CH; Fleisher AS; Carpenter A; Joshi AD; Lu M; Grundman M; Mintun MA; Skovronsky DM; Pontecorvo MJ; ;
    Mol Psychiatry; 2014 Sep; 19(9):1044-51. PubMed ID: 24614494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left lateralized cerebral glucose metabolism declines in amyloid-β positive persons with mild cognitive impairment.
    Weise CM; Chen K; Chen Y; Kuang X; Savage CR; Reiman EM;
    Neuroimage Clin; 2018; 20():286-296. PubMed ID: 30101060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.
    Bos I; Verhey FR; Ramakers IHGB; Jacobs HIL; Soininen H; Freund-Levi Y; Hampel H; Tsolaki M; Wallin ÅK; van Buchem MA; Oleksik A; Verbeek MM; Olde Rikkert M; van der Flier WM; Scheltens P; Aalten P; Visser PJ; Vos SJB
    Alzheimers Res Ther; 2017 Dec; 9(1):101. PubMed ID: 29284531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.
    Doraiswamy PM; Sperling RA; Coleman RE; Johnson KA; Reiman EM; Davis MD; Grundman M; Sabbagh MN; Sadowsky CH; Fleisher AS; Carpenter A; Clark CM; Joshi AD; Mintun MA; Skovronsky DM; Pontecorvo MJ;
    Neurology; 2012 Oct; 79(16):1636-44. PubMed ID: 22786606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Basal Forebrain Atrophy With Cognitive Decline in Early Alzheimer Disease.
    Xia Y; Dore V; Fripp J; Bourgeat P; Laws SM; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe C; Masters CL; Coulson EJ; Maruff P
    Neurology; 2024 Jul; 103(2):e209626. PubMed ID: 38885444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 'Comprehensive Visual Rating Scale' for predicting progression to dementia in patients with mild cognitive impairment.
    Jang JW; Park JH; Kim S; Park YH; Pyun JM; Lim JS; Kim Y; Youn YC; Kim S;
    PLoS One; 2018; 13(8):e0201852. PubMed ID: 30125290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial stiffness and dementia pathology: Atherosclerosis Risk in Communities (ARIC)-PET Study.
    Hughes TM; Wagenknecht LE; Craft S; Mintz A; Heiss G; Palta P; Wong D; Zhou Y; Knopman D; Mosley TH; Gottesman RF
    Neurology; 2018 Apr; 90(14):e1248-e1256. PubMed ID: 29549223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults.
    Dang C; Harrington KD; Lim YY; Ames D; Hassenstab J; Laws SM; Yassi N; Hickey M; Rainey-Smith SR; Robertson J; Rowe CC; Sohrabi HR; Salvado O; Weinborn M; Villemagne VL; Masters CL; Maruff P;
    Arch Clin Neuropsychol; 2019 Jul; 34(5):585-598. PubMed ID: 30272115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer's disease: a longitudinal cohort study.
    Van Hooren RWE; Riphagen JM; Jacobs HIL;
    Alzheimers Res Ther; 2018 Aug; 10(1):88. PubMed ID: 30153858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns.
    Lerch O; Ferreira D; Stomrud E; van Westen D; Tideman P; Palmqvist S; Mattsson-Carlgren N; Hort J; Hansson O; Westman E
    Alzheimers Res Ther; 2024 Jul; 16(1):153. PubMed ID: 38970077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.